Leslie D. Funtleyder insider trades

Open-market stock purchases and sales by Leslie D. Funtleyder, Chief Financial Officer at Applied Therapeutics, Inc, from SEC Form 4 filings since May 16, 2019.

Recent trades

DateStockTradeValue
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)$153K
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)$190K
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)—
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)—
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)$21.5K
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)$10.7K
Feb 3, 2026APLT Applied Therapeutics, IncSold (not open market)$17.3K
Jan 1, 2026APLT Applied Therapeutics, IncBought (not open market)—
Dec 19, 2025APLT Applied Therapeutics, IncBought (not open market)—
Dec 18, 2025RVPH Reviva Pharmaceuticals Holdings, IncBought (not open market)—

Companies traded

  • APLT Applied Therapeutics, Inc: 37 sales, last Feb 3, 2026
  • RVPH Reviva Pharmaceuticals Holdings, Inc: other filings, last Dec 18, 2025

Get free alerts when Leslie D. Funtleyder files a new trade →